The site of the Media Sphera Publishers contains materials intended solely for healthcare professionals.
By closing this message, you confirm that you are a certified medical professional or a student of a medical educational institution.

Mazina N.K.

Kirov State Medical Academy, Kirov

Mazin P.V.

Kirov State medical Academy, Kirov, Russia

The efficacy and safety of atezolizumab, nivolumab, and pembrolizumab as second-line therapy for non-small-cell lung cancer: preliminary data

Authors:

Mazina N.K., Mazin P.V.

More about the authors

Journal: P.A. Herzen Journal of Oncology. 2018;7(6): 80‑88

Views: 5916

Downloaded: 101


To cite this article:

Mazina NK, Mazin PV. The efficacy and safety of atezolizumab, nivolumab, and pembrolizumab as second-line therapy for non-small-cell lung cancer: preliminary data. P.A. Herzen Journal of Oncology. 2018;7(6):80‑88. (In Russ.)
https://doi.org/10.17116/onkolog2018706180

Email Confirmation

An email was sent to test@gmail.com with a confirmation link. Follow the link from the letter to complete the registration on the site.

Email Confirmation

We use cооkies to improve the performance of the site. By staying on our site, you agree to the terms of use of cооkies. To view our Privacy and Cookie Policy, please. click here.